PAVmed Q1 Adj. EPS $(1.17) Misses $(0.70) Estimate, Sales $22.000K Miss $74.000K Estimate.
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(1.17) per share which missed the analyst consensus estimate of $(0.70) by 67.14 percent. This is a 44.29 percent increase over losses of $(2.10) per share from the same